A Study to Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended⦠(NCT07061912) | Clinical Trial Compass
CompletedNot Applicable
A Study to Evaluate the Performance of INSTIĀ® HIV Self Test When Performed by Unobserved Intended Users in the US
Canada122 participantsStarted 2025-07-24
Plain-language summary
The objective of this study is to evaluate the performance of INSTIĀ® HIV Self Test with unobserved intended user population. The purpose of this study is to document if a lay person, unassisted by a healthcare worker, is able to perform the INSTIĀ® HIV Self Test correctly and without significant risk of incorrect results. The study aims to evaluate the clinical performance (i.e., diagnostic sensitivity and specificity) of the INSTIĀ® HIV Self-Test in a lay user population.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years of age or older
* Operator/study staff must complete the subject's Enrolment Questionnaire
* Subject to sign and date the Informed Consent Form
* Able to complete the required testing on the allocated testing day(s)
* Able to speak/ read/write English or Spanish
* Willingness to provide the fingerstick blood sample and if necessary, the volume of whole blood collected through venous blood draw (approximately 7 ml)
* Willingness to participate in the study site's standard of care HIV counselling and testing program and receive the study site's standard of care test results
* Unknown HIV Status or known HIV positive status with less than 12 months of ART
* For known HIV positive status subjects, willingness to share ART start date
Exclusion Criteria:
* Has participated in any prior, or concurrent trial of HIV self-tests
* Is a practicing medical healthcare professional (doctor, nurse or HIV Counsellor that performs HIV testing with Rapid Tests)
* Has used a Rapid Diagnostic Test for HIV blood-based self-testing previously
* Has received any experimental HIV vaccine
* Has a bleeding disorder
* Known HIV positive subjects and currently on an Anti-Retroviral Treatment (ART) for 12 months or longer and/or not willing to share ART start date
* Any condition which, in the opinion of the Operator, would make the participant unsuitable or unsafe for enrolment or could interfere with the completion of the assessment, consent form and questionnaire etc. ā¦
What they're measuring
1
Clinical sensitivity and specificity of the INSTIĀ® HIV Self-Test